4.2 Review

Surgical Treatment of Metabolic Syndrome

期刊

VISCERAL MEDICINE
卷 32, 期 5, 页码 352-356

出版社

KARGER
DOI: 10.1159/000449110

关键词

Obesity surgery; Metabolic surgery; Bariatric surgery; Metabolic syndrome; Type 2 diabetes mellitus; Sleeve gastrectomy; Gastric bypass; Biliopancreatic diversion; Duodenal switch

向作者/读者索取更多资源

Background: Bariatric surgery is gastrointestinal surgery for weight control, and metabolic surgery refers to the use of surgery to primarily and purposely treat type 2 diabetes mellitus (T2DM)/metabolic syndrome mellitus. Methods: The most recent literature was reviewed for surgery and T2DM in a non-systematic fashion. Results: Roux-Y gastric bypass, biliopancreatic diversion with duodenal switch, and sleeve gastrectomy (SG) are the dominant procedures today. SG is emerging as the most popular operation worldwide. Laparoscopy has made metabolic surgery as safe as other common abdominal procedures. A BMI > 60 kg/m(2), however, exposes a significantly higher perioperative risk. Most patients experience a sustained improvement of glycemic control with subsequent reduction of cardiovascular events. The remission rates depend on the severity and duration of diabetes. Prevention of long-term nutritional deficits and monitoring of metabolism require lifelong medical surveillance of the patients. Conclusions: The profound impact of weight reduction surgery on glucose metabolism explains the growing interest in treating T2DM by surgical means. Metabolic surgery is a safe option for carefully selected patients with metabolic syndrome. (C) 2016 S. Karger GmbH, Freiburg

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据